Building Crossroads, Partnerships & Making Deals

Thank you to all of our keynote speakers, sponsors, presenters, exhibitors and delegates. BPN 2012 was a great success with over 680 registered participants from 422 companies and 28 countries! BPN cultivated a productive networking atmosphere with 2026 scheduled meetings through biopartnering.com.

BioPartnering North America (BPN) focuses on the Pacific Rim because this is where a lot of life science business will be taking place in the years to come. We accomplished our plan to build on close ties with industry leaders in the Pacific Rim to create a unique opportunity for the U.S., Canada, and Europe to meet leading life science companies from Asia. BPN is a focused event for serious dealmakers!

    LEARN MORE

Keynote Address - AstraZeneca

Title: Bringing Global Reach and Local Experience to Partnerships:
Focus on Asia Pacific

        

Ms. Elaine Campbell, President and Chief Executive Officer,
AstraZeneca Canada Inc.

Listen to the recorded Keynote Session

Click here to listen to more audio recordings from BPN 2012.

Bringing Global Reach and Local Experience to Partnerships: Focus on Asia Pacific

Keynote Address - GlaxoSmithKline Canada

Title: Advancing the Commercialization of Canadian Life Sciences

         

Mr. Sav DiPasquale, Vice President Business Development and Corporate Planning, GlaxoSmithKline Canada

Listen to the recorded Keynote Session

Click here to listen to more audio recordings from BPN 2012.

Advancing the Commercialization of Canadian Life Sciences

Keynote Address - Pfizer

Title: Evolving Models of Innovation for Breakthrough Medicines: New Concepts at Pfizer

          

Dr. Uwe Schoenbeck, Chief Scientific Officer, Pfizer Inc.

Listen to the recorded Keynote Session

Click here to listen to more audio recordings from BPN 2012.

Evolving Models of Innovation for Breakthrough Medicines: New Concepts at Pfizer